XERIS BIOPHARMA HOLDINGS, INC. (XERS) Net income 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$554,000FY2025 · since FY2020: -$91.1M → $554,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $554,000 | +101.0% |
| FY2024 | -$54.8M | +11.9% |
| FY2023 | -$62.3M | +34.2% |
| FY2022 | -$94.7M | +22.9% |
| FY2021 | -$122.7M | -34.7% |
| FY2020 | -$91.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice